Clinical Trial Update: S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating thalidomide plus temozolomide for patients with stage IV melanoma that cannot be surgically removed has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Thalidomide (thalidomide)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED